{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T01:40:02Z","timestamp":1749692402020,"version":"3.41.0"},"reference-count":53,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Purpose<\/jats:title>\n                  <jats:p>Black persons comprise 13.4% of the US population but represent 36% of those with kidney failure. Medication-related disparities likely contribute to these outcomes. Patient perspective provides valuable insight into what they need and want from their medications and their care.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We conducted five 1.25-hour online focus group sessions via a videoconferencing app between March 30 and June 27, 2022. Our nationally recruited sample consisted of 19 adults 37 to 72 years of age who represented a broad range of educational backgrounds, all with CKD (non\u2013dialysis-dependent, dialysis-dependent, or post kidney transplant). Semistructured guides were constructed by our team and used by moderators. Inductive thematic analysis procedures were followed. Patients representative of our study population were integral members of our research team.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Our analysis includes 3 major themes and associated subthemes: (1) meet patients where they are (subthemes: patient autonomy and empowerment, experience with illness, home and community support, barriers to understanding, and barriers to access; (2) the patient journey with medications (subthemes: fears with medications, frustrations and burdens with medication use, adjusting to medications, desire for awareness and explanation, preferences with medications, and helpful tools and supports; and (3) significant interactions with healthcare professionals (subthemes: barriers to building trust, type of care and interactions desired, and care team communication).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Recognizing the patient as an individual, addressing their frustrations and needs with medications, and attending to implicit biases and strategies to overcome barriers and empower Black persons with CKD are anticipated to reduce medication- related disparities and improve health outcomes experienced by this population.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ajhp\/zxaf043","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T02:58:45Z","timestamp":1743389925000},"page":"710-718","source":"Crossref","is-referenced-by-count":0,"title":["Perspectives of medication-related experiences in Black persons with kidney diseases: The patient voice"],"prefix":"10.1093","volume":"82","author":[{"given":"Lisa A","family":"Hillman","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Care and Health Systems, University of Minnesota College of Pharmacy \u2013 Twin Cities , Minneapolis, MN ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Curtis","family":"Warfield","sequence":"additional","affiliation":[{"name":"National Kidney Foundation , Indianapolis, IN ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy L","family":"St. Peter","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Care and Health Systems, University of Minnesota College of Pharmacy \u2013 Twin Cities , Minneapolis, MN ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,3,28]]},"reference":[{"author":"United States Census Bureau","key":"2025061121162129100_CIT0001"},{"author":"United States Renal Data System","key":"2025061121162129100_CIT0002"},{"author":"US Centers for Disease Control and Prevention","key":"2025061121162129100_CIT0003"},{"issue":"289","key":"2025061121162129100_CIT0004","first-page":"1","article-title":"Hypertension prevalence and control among adults: United States, 2015\u20132016","author":"Fryar","year":"2017","journal-title":"NCHS Data Brief"},{"author":"United States Renal Data System","key":"2025061121162129100_CIT0005"},{"key":"2025061121162129100_CIT0006","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1053\/j.ajkd.2013.01.012","article-title":"Trajectories of kidney function decline in young black and white adults with preserved GFR: results from the Coronary Artery Risk Development in Young Adults (CARDIA) study","volume":"62","author":"Peralta","year":"2013","journal-title":"Am J Kidney Dis"},{"issue":"23","key":"2025061121162129100_CIT0007","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1056\/nejmoa2025845","article-title":"Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N Engl J Med"},{"issue":"9","key":"2025061121162129100_CIT0008","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1093\/ckj\/sfac069","article-title":"GLP-1 receptor agonists and renal outcomes in patients with diabetes mellitus type 2 and diabetic kidney disease: state of the art","volume":"15","author":"Granata","year":"2022","journal-title":"Clin Kidney J"},{"issue":"24","key":"2025061121162129100_CIT0009","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1056\/nejmoa1811744","article-title":"Canagliflozin and renal outcomes in type 2 diabetes and nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N Engl J Med"},{"issue":"8","key":"2025061121162129100_CIT0010","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1161\/CIRCULATIONAHA.121.055459","article-title":"Effect of the glucagon-like peptide-1 receptor agonists semaglutide and liraglutide on kidney outcomes in patients with type 2 diabetes: pooled analysis of SUSTAIN 6 and LEADER","volume":"145","author":"Shaman","year":"2022","journal-title":"Circulation"},{"issue":"4","key":"2025061121162129100_CIT0011","doi-asserted-by":"crossref","first-page":"e216139","DOI":"10.1001\/jamanetworkopen.2021.6139","article-title":"Association of race\/ethnicity, gender, and socioeconomic status with sodium-glucose cotransporter 2 inhibitor use among patients with diabetes in US","volume":"4","author":"Eberly","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"2","key":"2025061121162129100_CIT0012","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1089\/jwh.2020.8868","article-title":"Health equity among Black women in the United States","volume":"30","author":"Chinn","year":"2021","journal-title":"J Womens Health"},{"issue":"18","key":"2025061121162129100_CIT0013","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1001\/jama.2021.17764","article-title":"A policy prescription for reducing health disparities \u2013 achieiving pharmacoequity","volume":"326","author":"Essien","year":"2021","journal-title":"JAMA"},{"issue":"2","key":"2025061121162129100_CIT0014","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1159\/000479481","article-title":"Current state and future trends to optimize the care of chronic kidney disease in African Americans","volume":"46","author":"Harding","year":"2017","journal-title":"Am J Nephrol"},{"key":"2025061121162129100_CIT0015","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/jac5.1653","article-title":"Pharmacist\u2019s role in reducing medication-related racial disparities in African American patients with chronic kidney disease","volume":"5","author":"Gray","year":"2022","journal-title":"J Am Coll Clin Pharm"},{"issue":"6","key":"2025061121162129100_CIT0016","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1097\/MNH.0000000000000270","article-title":"Multimorbidity in people with chronic kidney disease: implications for outcomes and treatment","volume":"25","author":"Fraser","year":"2016","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"9","key":"2025061121162129100_CIT0017","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjopen-2018-023507","article-title":"Work of being an adult patient with chronic kidney disease: a systematic review of qualitative studies","volume":"8","author":"Roberti","year":"2018","journal-title":"BMJ Open"},{"issue":"4","key":"2025061121162129100_CIT0018","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1093\/ckj\/sfx140","article-title":"Adherence to medication in patients with chronic kidney disease: a systematic review of qualitative research","volume":"11","author":"Mechta Nielsen","year":"2017","journal-title":"Clin Kidney J"},{"key":"2025061121162129100_CIT0019","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1111\/jocn.13588","article-title":"Medication-taking behaviours in chronic kidney disease with multiple chronic conditions: a meta-ethnographic synthesis of qualitative studies","author":"Ellis","year":"2016"},{"issue":"3","key":"2025061121162129100_CIT0020","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1053\/j.ajkd.2010.04.021","article-title":"Medication adherence behavior and priorities among older adults with CKD: a semistructured interview study","volume":"56","author":"Rifkin","year":"2010","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"2025061121162129100_CIT0021","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1177\/1043659616651674","article-title":"Understanding experiences of diabetes medications among African Americans living with type 2 diabetes","volume":"28","author":"Bockwoldt","year":"2017","journal-title":"J Transcult Nurs"},{"key":"2025061121162129100_CIT0022","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2147\/PPA.S152146","article-title":"\u201cI did not want to take that medicine\u201d: African-Americans\u2019 reasons for diabetes medication nonadherence and perceived solutions for enhancing adherence","volume":"12","author":"Shiyanbola","year":"2018","journal-title":"Patient Prefer Adherence"},{"issue":"1","key":"2025061121162129100_CIT0023","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.sapharm.2004.12.007","article-title":"An inquiry into medication meanings, illness, medication use, and the transformative potential of chronic illness among African Americans with hypertension","volume":"1","author":"Viswanathan","year":"2005","journal-title":"Res Soc Adm Pharm"},{"issue":"4","key":"2025061121162129100_CIT0024","first-page":"469","article-title":"Factors influencing medication compliance among hypertensive older African American adults","volume":"23","author":"Rimando","year":"2013","journal-title":"Ethn Dis"},{"issue":"2","key":"2025061121162129100_CIT0025","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.xkme.2020.09.016","article-title":"Peter WL. Glucose-lowering medication use in CKD: analysis of US Medicare beneficiaries between 2007 and 2016","volume":"3","author":"Zhao","year":"2020","journal-title":"Kidney Med"},{"issue":"8","key":"2025061121162129100_CIT0026","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.xkme.2022.100510","article-title":"Hypoglycemia risk with SGLT-2i or glucagon-like peptide 1 receptor agonists versus sulfonylureas among Medicare insured adults with CKD in the United States","volume":"4","year":"2022","journal-title":"Kidney Med"},{"issue":"1","key":"2025061121162129100_CIT0027","doi-asserted-by":"publisher","first-page":"100564","DOI":"10.1016\/j.xkme.2022.100564","article-title":"Disparities in SGLT2 inhibitor or glucagon-like peptide 1 receptor agonist initiation among medicare insured adults with CKD in the United States","volume":"5","author":"Zhao","year":"2022","journal-title":"Kidney Med"},{"key":"2025061121162129100_CIT0028","volume-title":"Qualitative Research Design: An Interactive Approach","author":"Maxwell","year":"2013","edition":"3"},{"key":"2025061121162129100_CIT0029","volume-title":"Focus Groups: A Practical Guide for Applied Research","author":"Krueger","year":"2015","edition":"5"},{"author":"National Kidney Foundation","key":"2025061121162129100_CIT0030"},{"author":"American Association of Kidney Patients","key":"2025061121162129100_CIT0031"},{"author":"Advancing Kidney Health through Optimal Medication Management","key":"2025061121162129100_CIT0032"},{"issue":"2","key":"2025061121162129100_CIT0033","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","article-title":"Using thematic analysis in psychology","volume":"3","author":"Braun","year":"2006","journal-title":"Qual Res Psychol"},{"issue":"9","key":"2025061121162129100_CIT0034","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1097\/ACM.0000000000000388","article-title":"Standards for Reporting Qualitative Research: a synthesis of recommendations","volume":"89","author":"O\u2019Brien","year":"2014","journal-title":"Acad Med"},{"issue":"1","key":"2025061121162129100_CIT0035","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.pec.2018.08.029","article-title":"\u201cSame same or different?\u201d A review of reviews of person-centered and patient-centered care","volume":"102","author":"H\u00e5kansson Eklund","year":"2019","journal-title":"Patient Educ Counsel."},{"issue":"1","key":"2025061121162129100_CIT0036","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1080\/08964289.2020.1801570","article-title":"Cardiovascular disease and medication adherence among patients with type 2 diabetes mellitus in an underserved community","volume":"48","author":"McClintock","year":"2022","journal-title":"Behav Med"},{"issue":"1","key":"2025061121162129100_CIT0037","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/1471-2369-15-112","article-title":"Health care provider perception of chronic kidney disease: knowledge and behavior among African American patients","volume":"15","author":"Kazley","year":"2014","journal-title":"BMC Nephrol"},{"issue":"1","key":"2025061121162129100_CIT0038","doi-asserted-by":"publisher","first-page":"53","DOI":"10.37526\/1526-744x.2020.47.1.53","article-title":"Perspectives of African-American family members about kidney failure treatment","volume":"47","author":"DePasquale","year":"2020","journal-title":"Nephrol Nurs J"},{"issue":"1","key":"2025061121162129100_CIT0039","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.kint.2020.10.012","article-title":"The case for early identification and intervention of chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"99","author":"Shlipak","year":"2021","journal-title":"Kidney Int"},{"issue":"5","key":"2025061121162129100_CIT0040","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s11255-020-02452-8","article-title":"Factors affecting medication adherence among pre-dialysis chronic kidney disease patients: a systematic review and meta-analysis of literature.Int Urol Nephrol","volume":"52","author":"Seng","year":"2020"},{"issue":"4","key":"2025061121162129100_CIT0041","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.xkme.2022.100442","article-title":"Treating early-stage CKD with new medication therapies: results of a CKD patient survey informing the 2020 NKF-FDA Scientific Workshop on Clinical Trial Considerations for Developing Treatments for Early Stages of Common, Chronic Kidney Diseases","volume":"4","author":"Damron","year":"2022","journal-title":"Kidney Med"},{"issue":"6","key":"2025061121162129100_CIT0042","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1080\/10410236.2012.710873","article-title":"Patient trust in physicians and shared decision-making among African-Americans with diabetes","volume":"28","author":"Peek","year":"2013","journal-title":"Health Commun"},{"key":"2025061121162129100_CIT0043","doi-asserted-by":"publisher","first-page":"e138","DOI":"10.3928\/24748307-20200617-01","article-title":"Health Literacy in African-American communities: barriers and strategies. Heal Lit Res Pract","author":"Muvuka","year":"2020"},{"issue":"7","key":"2025061121162129100_CIT0044","doi-asserted-by":"publisher","first-page":"937","DOI":"10.2215\/CJN.00900120T","article-title":"Patient and caregiver perspectives on terms used to describe kidney health","volume":"15","author":"Tong","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"2025061121162129100_CIT0045","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/s11606-019-05540-3","article-title":"Awareness and discussions about chronic kidney disease among African-Americans with chronic kidney disease and hypertension: a mixed methods study","volume":"35","author":"Murphy","year":"2020","journal-title":"J Gen Intern Med"},{"issue":"8","key":"2025061121162129100_CIT0046","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1080\/10810730.2020.1827098","article-title":"Evaluating a health literacy communication training for medical students: using plain language","volume":"25","author":"Hildenbrand","year":"2020","journal-title":"J Health Commun"},{"issue":"1","key":"2025061121162129100_CIT0047","doi-asserted-by":"publisher","first-page":"76","DOI":"10.5688\/ajpe8200","article-title":"Inclusion of health disparities, cultural competence, and health literacy content in US and Canadian pharmacy curriculums","volume":"85","author":"Chen","year":"2021","journal-title":"Am J Pharm Educ"},{"key":"2025061121162129100_CIT0048","doi-asserted-by":"publisher","DOI":"10.1177\/1745506520953348","article-title":"\u201cWe get double slammed!\u201d: healthcare experiences of perceived discrimination among low-income African-American women","volume":"16","author":"Okoro","year":"2020","journal-title":"Womens Health (Lond)"},{"issue":"1","key":"2025061121162129100_CIT0049","doi-asserted-by":"publisher","DOI":"10.1186\/s12910-017-0179-8","article-title":"Implicit bias in healthcare professionals: a systematic review","volume":"18","author":"Fitzgerald","year":"2017","journal-title":"BMC Med Ethics"},{"issue":"1","key":"2025061121162129100_CIT0050","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3390\/pharmacy6010013","article-title":"Giving voice to the medically underserved: a qualitative co-production approach to explore patient medicine experiences and improve services to marginalized communities","volume":"6","author":"Latif","year":"2018","journal-title":"Pharmacy (Basel)"},{"issue":"1","key":"2025061121162129100_CIT0051","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/pharmacy10010014","article-title":"A qualitative analysis to understand perception about medication-related problems among older minority adults in a historically black community","volume":"10","author":"Poon","year":"2022","journal-title":"Pharmacy (Basel)"},{"key":"2025061121162129100_CIT0052","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s40615-020- 00850-3","article-title":"Poor medication adherence in African Americans Is a matter of trust. J Racial Ethn Heal Disparities","author":"Hall","year":"2021"},{"key":"2025061121162129100_CIT0053","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.2147\/PPA.S371162","article-title":"Interventions incorporating therapeutic alliance to improve medication adherence in Black patients with diabetes, hypertension and kidney disease: a systematic review","volume":"16","author":"Desta","year":"2022","journal-title":"Patient Prefer Adherence"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajhp\/advance-article-pdf\/doi\/10.1093\/ajhp\/zxaf043\/62520505\/zxaf043.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajhp\/article-pdf\/82\/12\/710\/62520505\/zxaf043.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajhp\/article-pdf\/82\/12\/710\/62520505\/zxaf043.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T01:16:30Z","timestamp":1749690990000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/82\/12\/710\/8090044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,28]]},"references-count":53,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,3,28]]},"published-print":{"date-parts":[[2025,6,11]]}},"URL":"https:\/\/doi.org\/10.1093\/ajhp\/zxaf043","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"type":"print","value":"1079-2082"},{"type":"electronic","value":"1535-2900"}],"subject":[],"published-other":{"date-parts":[[2025,6,15]]},"published":{"date-parts":[[2025,3,28]]}}}